Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Rao, Krishnamurthy"'
Autor:
Takhi, Mohamed, Sreenivas, Kandepu, Reddy, Chandrashekar K., Munikumar, Mahadari, Praveena, Kolakota, Sudheer, Pabolu, Rao, Bandaru N.V.M., Ramakanth, Gollamudi, Sivaranjani, Jampala, Mulik, Shardaprasad, Reddy, Yeruva R., Narasimha Rao, Krishnamurthy, Pallavi, Rentala, Lakshminarasimhan, Anirudha, Panigrahi, Sunil K., Antony, Thomas, Abdullah, Iskandar, Lee, Yean K., Ramachandra, Murali, Yusof, Rohana, Rahman, Noorsaadah A., Subramanya, Hosahalli
Publikováno v:
In European Journal of Medicinal Chemistry 12 September 2014 84:382-394
Autor:
Suttisansanee, Uthaiwan, Lau, Kelvin, Lagishetty, Satyanarayana, Rao, Krishnamurthy N., Swaminathan, Subramanyam, Sauder, J. Michael, Burley, Stephen K., Honek, John F.
Publikováno v:
In Journal of Biological Chemistry 4 November 2011 286(44):38367-38374
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1988 Mar . 85(6), 1787-1791.
Externí odkaz:
https://www.jstor.org/stable/31390
Publikováno v:
The Journal of Cell Biology, 1986 Mar 01. 102(3), 951-958.
Externí odkaz:
https://www.jstor.org/stable/1611893
Autor:
Klausner, Richard D., Van Renswoude, Jos, Kempf, Christoph, Rao, Krishnamurthy, Bateman, Judith L., Robbins, April R.
Publikováno v:
The Journal of Cell Biology, 1984 Mar 01. 98(3), 1098-1101.
Externí odkaz:
https://www.jstor.org/stable/1610851
Autor:
Manoj Pothuganti, Suraj T Gore, Narasimha Rao Krishnamurthy, Sunil Shivaji More, Sumalatha Rani Talapati, Thomas Antony, Murali Ramachandra, Vijayashankar Nataraj
Publikováno v:
Acta Crystallogr F Struct Biol Commun
CVT-313 is a potent CDK2 inhibitor that was identified by screening a purine-analogue library and is currently in preclinical studies. Since this molecule has the potential to be developed as a CDK2 inhibitor for cancer therapy, the potency of CVT-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6858cfcf63b5d46162b270a5fb6d94c9
https://europepmc.org/articles/PMC7397463/
https://europepmc.org/articles/PMC7397463/
Autor:
Bharat Lagu, Eric L. Bell, Effie Tozzo, Nirbhay Kumar Tiwari, Andrew Basinski, Arthur F. Kluge, Matthew M. Goddeeris, Ramesh S. Senaiar, Narasimha Rao Krishnamurthy, Ross Fredenburg, Sunil Kumar Panigrahi, Michael A. Patane, Mahaboobi Jaleel, Taisuke Takahashi, Peter Dwyer
Publikováno v:
ACS Medicinal Chemistry Letters. 9:935-940
The X-ray structure of the previously reported PPARδ modulator 1 bound to the ligand binding domain (LBD) revealed that the amide moiety in 1 exists in the thermodynamically disfavored cis-amide orientation. Isosteric replacement of the cis-amide wi
Autor:
Lakshmi Narayan Kaza, Thomas Anthony, Sunil Kumar Pnaigrahi, Aditya Kiran Gatta, Kiran Aithal, Pravin Pise, Vijay Kamal Ahuja, Narasimha Rao Krishnamurthy, Sanjeev Giri, Vinayak Khairnar, Narasimha Raju Kalidindi, Murali Ramachandra, KB Charamannna, Nirbhay Kumar Tiwari, Susanta Samajdar, Vijaya Shankar Nataraj, Dinesh Chikkanna, Shekar Chelur, Kavitha Nellore, Manoj Pothuganti, Sandeep Patil, DS Samiulla, Leena Khare Satyam
Publikováno v:
Cancer Research. 81:1266-1266
Dysregulated fatty acid metabolism is thought to be a hallmark of cancer, wherein fatty acids function both as an energy source and as signals for enzymatic and transcriptional networks contributing to malignancy. Fatty acid-binding protein 5 (FABP5)
Publikováno v:
In Toxicon 2005 45(7):929-939
Autor:
Mahaboobi Jaleel, Matthew M. Goddeeris, Ramesh S. Senaiar, Peter Dwyer, Eric L. Bell, Sunil Kumar Panigrahi, Ross Fredenburg, Bharat Lagu, Narasimha Rao Krishnamurthy, Andrew Basinski, Michael A. Patane, Nirbhay Kumar Tiwari, Taisuke Takahashi, Effie Tozzo, Arthur F. Kluge
[Image: see text] The X-ray structure of the previously reported PPARδ modulator 1 bound to the ligand binding domain (LBD) revealed that the amide moiety in 1 exists in the thermodynamically disfavored cis-amide orientation. Isosteric replacement o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6579f783424d3bdf0cdce8fc284c2809
https://europepmc.org/articles/PMC6580794/
https://europepmc.org/articles/PMC6580794/